INTUITIVE SURGICAL INC Quarterly Report for Q1 Ended Mar 31, 2016

Summary

Intuitive Surgical Inc. (ISRG) demonstrated strong financial performance in the first quarter of 2016, with total revenue increasing by 12% year-over-year to $594.5 million. This growth was primarily fueled by a 14% increase in recurring revenue, which now constitutes 75% of total revenue, underscoring the company's successful business model centered on ongoing instrument, accessory, and service sales. Procedure volume saw a significant 17% increase, reaching approximately 176,000 procedures performed worldwide. This robust procedure growth, particularly in general surgery and urology, translated into a 16% rise in instrument and accessory revenue. The company also reported improved profitability, with gross profit increasing by 20% and operating income surging by 37% due to higher revenues, improved gross margins, and effective cost management. ISRG ended the quarter with a strong cash position of $3.8 billion, indicating sound financial health and flexibility.

Key Highlights

• 1Total revenue grew 12% to $594.5 million in Q1 2016.
• 2Recurring revenue (instruments, accessories, service) increased 14% to $446.6 million, representing 75% of total revenue.
• 3Worldwide da Vinci procedures increased 17% year-over-year to approximately 176,000.
• 4Instrument and accessory revenue rose 16% to $322.1 million, driven by procedure volume.
• 5Gross profit increased 20% to $405.0 million, with gross margin improving to 68.1% from 63.3% in the prior year period.
• 6Operating income surged 37% to $179.0 million, reflecting revenue growth and margin expansion.
• 7The company maintained a strong liquidity position with $3.8 billion in cash, cash equivalents, and investments as of March 31, 2016.

Frequently Asked Questions